INSERM (Institut National de la Santé et de la Recherche Médicale);Université d'Aix-Marseille;Centre National de la Recherche Scientifique (CNRS);Universidad de Navarra
The invention relates to a modified bacterium belonging to the Brucella genus that carries an inactivated wadC gene and an inactivated ppdK gene and to uses thereof. The invention also relates to a vaccine against brucellosis in human and/or animals comprising a modified bacterium belonging to the Brucella genus that carries an inactivated wadC gene and an inactivated ppdK gene.